Comments

Rigel Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Rigel Pharmaceuticals (RIGL) operate in?

Rigel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

RIGLNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Tue May 6th, after the market close

The most recent conference call was at 16:30 PM, 7 days ago Click to view past webcast

Rigel Pharmaceuticals (RIGL) Forecast

News Earnings Rigel Pharmaceuticals (RIGL) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Rigel Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:RIGL | Benzinga

Explore Rigel Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RIGL.

Open	$18.47
Close	-
Volume / Avg.	54.16K / 223.25K
Day Range	$17.65 - $18.47
52 Wk Range	7.48 - 29.82
Market Cap	$321.88M
P/E Ratio	8.90
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	10.64%
Days to Cover	12.36

Recent News

Rockwell Automation Posts Better-Than-Expected Earnings, Joins Oscar Health, Charles River Laboratories, Walt Disney, Voya Financial And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Wall Street Awaits Trump's Tariff Decision, Digests Mixed Economic Data: What's Driving Markets Wednesday?

The three major indices were mostly flat in midday trading Wednesday with the S&P 500 and Nasdaq slightly under the flatline and the Dow Jones up 39 points.

Erica Kollmann

Stocks Drop As Trade War Escalates: What's Driving Markets Tuesday?

U.S. stocks plunged Tuesday as President Donald Trump‘s tariffs on key trade partners came into effect, prompting retaliatory measures and intensifying global trade tensions.

Erica Kollmann

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$18.47
Close	-
Volume / Avg.	54.16K / 223.25K
Day Range	$17.65 - $18.47
52 Wk Range	7.48 - 29.82
Market Cap	$321.88M
P/E Ratio	8.90
Dividend Yield	-
Exchange	NASDAQ
RSI	46
Short Interest	10.64%
Days to Cover	12.36

About Rigel Pharmaceuticals

Sector

Health Care

Industry

Biotechnology

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral di...

Got Questions? Ask

Analyze RIGL's market performance

What is RIGL's 7 days volume trend?

What is RIGL's ROA?

What is the Pivot support level for RIGL?

What’s the latest news on RIGL?

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Rigel Pharmaceuticals (RIGL) stock?

You can purchase shares of Rigel Pharmaceuticals (NASDAQ:RIGL) through any online brokerage.

View our list of the best stock brokerages

Who are Rigel Pharmaceuticals (RIGL) competitors?

Other companies in Rigel Pharmaceuticals’s space includes: Tectonic Therapeutic (NASDAQ:TECX), aTyr Pharma (NASDAQ:ATYR), Olema Pharmaceuticals (NASDAQ:OLMA), Emergent BioSolutions (NYSE:EBS) and ORIC Pharmaceuticals (NASDAQ:ORIC).

What is the forecast, or price target, for Rigel Pharmaceuticals (RIGL) stock?

Rigel Pharmaceuticals has a consensus price target of $26.71.

What is the current price for Rigel Pharmaceuticals (RIGL)?

The stock price for Rigel Pharmaceuticals (NASDAQ: RIGL) is $18.0099 last updated May 13, 2025 at 11:32 AM EDT.

Does Rigel Pharmaceuticals (RIGL) pay a dividend?

There are no upcoming dividends for Rigel Pharmaceuticals.

When is Rigel Pharmaceuticals (NASDAQ:RIGL) reporting earnings?

Rigel Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 5, 2025.

Is Rigel Pharmaceuticals (RIGL) going to split?

There is no upcoming split for Rigel Pharmaceuticals.

What sector and industry does Rigel Pharmaceuticals (RIGL) operate in?

Rigel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.